Cocrystal Pharma Inc. (COCP)
NASDAQ: COCP
· Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.72
1.11%
After-hours: Aug 15, 2025, 04:31 PM EDT
1.19% (1D)
| Bid | 1.59 |
| Market Cap | 17.3M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -15.85M |
| EPS (ttm) | -1.56 |
| PE Ratio (ttm) | -1.09 |
| Forward PE | -1.78 |
| Analyst | Buy |
| Ask | 1.72 |
| Volume | 38,186 |
| Avg. Volume (20D) | 71,409 |
| Open | 1.68 |
| Previous Close | 1.68 |
| Day's Range | 1.64 - 1.70 |
| 52-Week Range | 1.12 - 3.26 |
| Beta | 2.07 |
About COCP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol COCP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for COCP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+9.09%
Cocrystal Pharma shares are trading higher after t...
Unlock content with
Pro Subscription
7 months ago
+6.64%
Cocrystal Pharma shares are trading higher after the company announced Phase 1 results for its oral broad-acting antiviral drug CDI-988.
